Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on solvent free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590799B reveals a novel melt-acetylation route for isosorbide dinitrate isomers, offering high-purity pharmaceutical intermediates with reduced environmental impact.
Patent CN102702270A reveals solvent-free rhodium catalyst synthesis reducing toxic waste and improving yield for industrial chemical manufacturing supply chains.
Novel solvent-free oxidation process for 4-palmitoyloxy-2-methyl-2-butenal improves yield and reduces environmental impact for scalable vitamin production.
Patent CN111995614B reveals a novel gas-solid synthesis for thiohydroxy acetic anhydride. Achieve higher purity and yield for erdosteine production with reduced solvent usage.
Patent CN101225027A reveals a solvent-free zinc-catalyzed route for stilbene synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel solvent-free chloromethylation process for high-purity antioxidant intermediates, offering significant cost reduction and environmental compliance for polymer additive manufacturing.
Novel solvent-free synthesis of PinB(DMA) offers high purity and stability for API manufacturing, reducing costs and supply chain risks significantly.
Patent CN103880728A reveals a solvent-free, room-temperature method for producing high-purity diindolylmethane compounds using reusable acidic ionic liquids, offering significant cost and environmental advantages.
Patent CN101372476B reveals solvent-free pyrazole synthesis offering high yield and atom economy for reliable pharmaceutical intermediate supply chains.
Patent CN111606838B reveals a green hydrothermal method for bis-indolylmethane synthesis, eliminating toxic catalysts and reducing waste for reliable pharma intermediate supply.
Patent CN119954669A details a mild solvent-free route for SNAC. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN102209723B enables high-purity ligand synthesis with solvent-free methods. Delivers substantial cost reduction and supply chain reliability for global buyers.
Novel solvent-free route for 4-isobutyl pyrrolidone ensures high purity and cost efficiency for pregabalin supply chains.
Patent CN116554062A reveals solvent-free synthesis for high-purity Pregabalin Impurity II. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel solvent-free patent method ensures high purity DCC for peptide synthesis. Reduces cost and environmental impact for reliable pharmaceutical intermediate supply chains.
Novel solvent-free synthesis of anticancer intermediate CN102911177A. High yield, green chemistry, scalable for API manufacturing.
Patent CN112479975A reveals a green, solvent-free route for N-alkyl phthalimide with >99% purity, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN111747859A reveals a solvent-free synthesis route for N-(2,6-xylyl) methyl aminopropionate, offering high yields up to 97% and reduced environmental impact for fungicide manufacturing.
Patent CN102766081A reveals a green, solvent-free route for bis-indolylmethane derivatives using reusable ionic liquids, offering significant cost and supply chain advantages.
Advanced solvent-free synthesis patent ensures high-purity antioxidant intermediates. Significant cost reduction and supply chain reliability for polymer additive manufacturing.